期刊文献+

顺铂与氯霉素联用增强对人肺腺癌A549细胞的抑制作用

The interaction between cisplatin and chloramphenicol on human lung adenocarcinoma cell line A549
下载PDF
导出
摘要 目的体外观察顺铂和氯霉素对人肺腺癌A549细胞的相互作用。方法采用MTT法,利用中效原理判定联合应用顺铂及氯霉素对人肺腺癌A549细胞的效应。结果顺铂与氯霉素联用可以明显抑制人肺腺癌A549细胞的生长,两药单用和联用时随着药物浓度增加,其效应也增加;两药联用时的中效浓度明显小于两药单独使用时的中效浓度(顺铂减少43.8%,氯霉素减少79.1%);两药大剂量合用时为拮抗效应(CI>1),小剂量合用时为协同效应(CI<1);并且两药合用时的效应与给药的时间先后次序无关(P>0.05)。结论顺铂与氯霉素的联用可以明显抑制人肺腺癌A549细胞的生长,两药联用时的中效浓度较单用时明显减小;上述两种药合用时大剂量为拮抗,小剂量为协同;两药合用时的效应与给药的时间先后次序无关。 Objective To observe the interaction between cisplatin and chloramphenicol on human lung adenocarcinoma cell line A549.Methods The anticancer effect of the drugs was detected with MTT.The median-effect principle was used.Results The combination of cisplatin and chloramphenicol significantly inhibited the growth of human lung adenocarcinoma cell line A549.Anticancer effects of the individual and combined drugs enhanced as drug concentration increased.The 50% inhibited concentration of each drugs in combination was lesser than the concentration of each individual drugs.(Cisplatin decreased of 43.8%,Chloramphenicol decreased of 79.1%).The combination of the two drugs at higher concentration the CI was more than 1,and the combinations at lower concentration the CI was less than 1.The sequence of administration did not influence the anticancer effects(P〉0.05).Conclusion The combination of cisplatin and chloramphenicol significantly inhibited the growth of human lung adenocarcinoma cell line A549.The 50% inhibited concentration of each drugs in combination was lesser than the concentration of each individual drugs.The combined drugs interaction was antagonistic at higher concentration and synergistic at lower concentration.The sequence of administration did not influence the anticancer effects.
出处 《云南医药》 CAS 2012年第4期346-349,共4页 Medicine and Pharmacy of Yunnan
关键词 肺腺癌A549细胞 顺铂 氯霉素 中效原理 合用指数 Lung adenocarcinoma cell line A549 Cisplatin Chloramphenicol Median-effect principle Combination index
  • 相关文献

参考文献9

二级参考文献17

  • 1钱频,戢福云,钱桂生,黄桂君,陈琰,郭芮琳.顺铂诱导人小细胞肺癌多药耐药细胞系NCI-H446/CDDP的建立及其生物学特征分析[J].解放军医学杂志,2004,29(12):1052-1054. 被引量:11
  • 2[3]Fan W,Everett ET,Tan C,et al.Glucocorticoid-mediated inhibition of toxol-induced apoptosis in leiomyosarcoma cells.Cell Pharmacol,1994,1(2)∶205-213.
  • 3[4]Miquel K,Pradines A,Favre G.Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells.Biochem Biophys Res Commun,1996,225(3)∶869-876.
  • 4[5]Efferth T,Rucker G,Falkenberg M,et al.Detection of apoptosis in KG-1α Leukemic cells treated with investigational drugs.Arzneimittel Forschung,1996,46(2)∶196-200.
  • 5[1]Lowe SW,Ruley HE,Jacks T,et al.p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.Cell,1993,74(6)∶957-967.
  • 6[2]Lutzker SG,Levine AJ.Apoptosis and cancer chemotherapy.Cancer Treat Res,1996,87∶345-356.
  • 7Fan W,Cell Pharmacol,1994年,1期,205页
  • 8Olivero OA,Chong PK,Lopez-Larraza DM et al.Preferential formation and decrease removal of cisplatin -DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA.Mutant Res,1997,391(1-2):79
  • 9Becker R,Laube H.Insulin resistance in patients with the mitochondrial tRNA(Leu(UUR)) gene mutation at position 3243.Exp Clin Endocrinol Diabetes,2002,110(6): 291
  • 10Nutt LK,Chandra J,Pataer AB et al.Bax-mediated Ca2t mobilization promotes cytochrome c release during apoptosis.Developmental Cell,2002,2(1):55

共引文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部